# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Ovarian cancer

Cancer, Ovarian
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 11-20 of 614 results.
Clinical Study of Apatinib in the Treatment of Platinum Resistant Recurrent Ovarian Cancer
Status: Recruiting
Last Changed: Sep 04, 2018
First Received: Jul 16, 2018
Disease(s): Ovarian Cancer
Intervention(s): Apatinib
Locations: The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China
Restrictive or Individualized Goal-Directed Fluid Replacement Strategy in Ovarian Cancer Cytoreductive Surgery
Status: Recruiting
Last Changed: May 08, 2018
First Received: May 08, 2018
Disease(s): Ovarian Cancer
Intervention(s): EV1000(FloTrac System 4.0)
Locations: Tata Medical Centre, Kolkata, West Bengal, India
Laboratory Study of Cancer & Immune Cells in Ascites Fluid of Ovarian Cancer Patients to Test Alternative Therapies
Status: Recruiting
Last Changed: Dec 20, 2019
First Received: May 09, 2019
Disease(s): Ovarian Cancer
Locations: University of New Mexico Cancer Center, Albuquerque, New Mexico, United States
MESO-CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer
Status: Recruiting
Last Changed: Apr 10, 2019
First Received: Jan 10, 2019
Disease(s): Ovarian Cancer
Intervention(s): anti-MESO CAR-T cells, Fludarabine, Cyclophosphamide
Locations: The Second Affiliated hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
MESO-CAR T Cells Therapy for Relapsed and Refractory Epithelial Ovarian Cancer
Status: Recruiting
Last Changed: Apr 16, 2019
First Received: Apr 16, 2019
Disease(s): Ovarian Cancer
Intervention(s): anti-MESO CAR-T cells
Locations: The Second Affiliated hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Genetically Modified T Cells Against Ovarian Cancer
Status: Recruiting
Last Changed: Sep 19, 2019
First Received: Jun 14, 2017
Disease(s): Ovarian Cancer
Intervention(s): OC-IgT cells
Locations: Shenzhen Geno-immune Medical Institute, Shenzhen, Guangdong, China
The Fourth Generation CART-cell Therapy for Refractory-Relapsed Ovarian Cancer
Status: Recruiting
Last Changed: Aug 26, 2019
First Received: Jan 24, 2019
Disease(s): Ovarian Cancer
Intervention(s): anti- MESO CAR-T cells, Fludarabine, Cyclophosphamide
Locations: Shanghai 6th People's Hospital, Shanghai, Shanghai, China
Treatment for Malignant Ovarian Cancer: Laparoscopy vs Laparotomy
Status: Not yet recruiting
Last Changed: Feb 19, 2016
First Received: Feb 19, 2016
Disease(s): Ovarian Cancer
Intervention(s): Laparoscopy, Laparotomy
Imaging Study in Advanced Ovarian Cancer
Status: Not yet recruiting
Last Changed: Jan 18, 2019
First Received: Jan 18, 2019
Disease(s): Ovarian Cancer
Intervention(s): Ultrasound, CT and WB-DWI/MRI
Locations: Gynecologic Oncology Center in Prague, Prague, Czechia
Genes Contributing to Hereditary Ovarian Cancer in Women and BRCA1/2 Wildtype Families
Status: Recruiting
Last Changed: May 17, 2019
First Received: Apr 18, 2017
Disease(s): Ovarian Cancer
Locations: University of Washington, Seattle, Washington, United States